For example, plasma cathepsin D levels showed a non-significant downward trend in infants with SMA compared to age-matched healthy controls in baseline measurements from the NeuroNEXT biomarker study (p > 0.05) [141]. Here, CTSD is linked to proximal spinal muscular atrophy.